Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

v3.10.0.1
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Aug. 31, 2018
Aug. 31, 2017
Aug. 31, 2018
Aug. 31, 2017
REVENUES $ 6,230 $ 2,562 $ 12,853 $ 6,712
COST OF REVENUES 3,381 1,867 7,220 4,900
GROSS PROFIT 2,849 695 5,633 1,812
RESEARCH AND DEVELOPMENT EXPENSES, net 1,902 500 3,456 1,906
AMORTIZATION OF INTANGIBLE ASSETS 505 423 1,386 1,201
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES 4,008 3,184 10,675 7,887
OTHER INCOME, net (2,921) 0 (3,237) 0
OPERATING LOSS 645 3,412 6,647 9,182
FINANCIAL EXPENSES (INCOME), net 1,070 (45) 3,164 2,534
SHARE IN LOSSES OF ASSOCIATED COMPANY 202 152 732 348
LOSS BEFORE INCOME TAXES 1,917 3,519 10,543 12,064
TAX EXPENSES 2,353 421 1,680 493
NET LOSS 4,270 3,940 12,223 12,557
NET INCOME ATTRIBUTABLE TO NON-CONTROLLING INTERESTS (INCLUDING REDEEMABLE) 800 0 1,072 0
NET LOSS ATTRIBUTABLE TO THE COMPANY $ 5,070 $ 3,940 $ 13,295 $ 12,557
LOSS PER SHARE:        
Basic $ (0.35) $ (0.38) $ (1.04) $ (1.32)
Diluted $ (0.35) $ (0.40) $ (1.04) $ (1.34)
WEIGHTED AVERAGE NUMBER OF SHARES USED IN COMPUTATION OF BASIC AND DILUTED LOSS PER SHARE:        
Basic 14,355,430 10,279,180 12,774,802 9,477,211
Diluted 14,355,430 10,385,499 12,774,802 9,503,253
OTHER COMPREHENSIVE LOSS:        
Net Loss $ 4,270 $ 3,940 $ 12,223 $ 12,557
Other Comprehensive (income) loss - Translation adjustment 416 (1,430) 765 (2,419)
Comprehensive loss 4,686 2,510 12,988 10,138
Net income attributed to non-controlling interests (including redeemable) 800 0 1,072 0
COMPREHENSIVE LOSS ATTRIBUTED TO ORGENESIS INC. $ 5,486 $ 2,510 $ 14,060 $ 10,138